HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment

  • Avidan U. Neumann
  • , Roland Tubiana
  • , Vincent Calvez
  • , Catherine Robert
  • , Tai Sheng Li
  • , Henri Agut
  • , Brigitte Autran
  • , Christine Katlama

Research output: Contribution to journal › Article › peer-review

163 Scopus citations

Fingerprint

Dive into the research topics of 'HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science